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Abstract
Introduction: The most appropriate tidal volume in patients without acute respiratory distress syndrome (ARDS) is
controversial and has not been rigorously examined. Our objective was to determine whether a mechanical
ventilation strategy using lower tidal volume is associated with a decreased incidence of progression to ARDS
when compared with a higher tidal volume strategy.
Methods: A systematic search of MEDLINE, EMBASE, CINAHL, the Cochrane Library, conference proceedings, and
clinical trial registration was performed with a comprehensive strategy. Studies providing information on
mechanically ventilated patients without ARDS at the time of initiation of mechanical ventilation, and in which
tidal volume was independently studied as a predictor variable for outcome, were included. The primary outcome
was progression to ARDS.
Results: The search yielded 1,704 studies, of which 13 were included in the final analysis. One randomized
controlled trial was found; the remaining 12 studies were observational. The patient cohorts were significantly
heterogeneous in composition and baseline risk for developing ARDS; therefore, a meta-analysis of the data was
not performed. The majority of the studies (n = 8) showed a decrease in progression to ARDS with a lower tidal
volume strategy. ARDS developed early in the course of illness (5 hours to 3.7 days). The development of ARDS
was associated with increased mortality, lengths of stay, mechanical ventilation duration, and nonpulmonary organ
failure.
Conclusions: In mechanically ventilated patients without ARDS at the time of endotracheal intubation, the
majority of data favors lower tidal volume to reduce progression to ARDS. However, due to significant
heterogeneity in the data, no definitive recommendations can be made. Further randomized controlled trials
examining the role of lower tidal volumes in patients without ARDS, controlling for ARDS risk, are needed.
2013 Fuller et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
Close to 200,000 cases of acute lung injury (ALI) or acute
respiratory distress syndrome (ARDS) occur annually in
the United States [1,2]. It remains a leading cause of
death in critically ill patients, with a mortality rate of
approximately 30%, but as high as 60% in the elderly
[1,3,4]. ARDS also represents a large societal burden,
accounting for 3.6 million hospital days annually and sig-
nificant long-term sequelae in survivors [1,3]. These
include various neuropsychological impairments (e.g.
depression, cognitive decline), persistent weakness and
pulmonary dysfunction, and decreased quality of life
[3,5].Unfortunately, the number of ARDS trials demon-
strating improved clinical outcomes are far outnumbered
by those that have not [6-21]. In patients with ARDS, the
current body of evidence supports a lower tidal volume
strategy as best practice [6].
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In contrast, the optimal tidal volume in patients with-
out ARDS is uncertain [22,23]. Historically, it was
thought that high tidal volume not only was safe, but
also was preferred to avoid the hypoxia, atelectasis, and
acidosis associated with mechanical ventilation with
lower tidal volumes [24-26]. This led to the common
use of tidal volumes in the 12- to 15-ml/kg range [27].
However, experimental data suggest that tidal volume is
a major contributor to the development of lung injury
[28]. Clinical data in intensive care unit (ICU) patients
also suggests that larger tidal volume may contribute to
the development of ARDS [29-31], suggesting that this
syndrome may in part be preventable. However, this evi-
dence has been inconclusive, because of observational
trial design, small sample sizes, and lack of reproducibil-
ity in different patient populations [32,33]. In patients
without lung injury at the time of endotracheal intuba-
tion, progression to ARDS can occur over the course of
hours and may increase mortality by >30% [30,34,35].
This has led to increased interest in ARDS prevention
and the examination of a lower tidal volume strategy to
prevent its development in patients without lung injury.
We therefore aimed to systematically review the evi-
dence regarding the role of tidal volume as a contributor
to ARDS progression in patients without ARDS. The
objectives of this study were to perform a systematic
review of the literature comprising a comprehensive
search strategy and standardized analysis techniques to
determine whether lower tidal volumes, compared with
higher tidal volumes, are associated with a decreased
incidence of ARDS in mechanically ventilated patients.
We hypothesized that lower tidal volume ventilation is
associated with a decrease in progression to ARDS in
mechanically ventilated patients, but the existing litera-
ture lacks the methodologic quality to provide definitive
recommendations for the best tidal volume in patients
without ARDS.
Materials and methods
This systematic review was designed, conducted, and
reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis (PRISMA) and
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [36,37]. It did not require ethical
approval from Washington University Human Research
Protection Office. It is recognized that ALI and ARDS
have undergone recent definitional change [38]. Although
the definitional criteria in place during the systematic
search for clinical trials, as well as the conduct of each
study, was the American-European Consensus Conference
(AECC) criteria, for consistency in reporting according to
the new Berlin definition, we use the term ARDS to refer
to both ARDS and ALI (as reported in previous literature)
[2,38].
Search for and identification of studies
We followed a written protocol (see Additional file 1) that
was finalized before beginning the search. We initiated our
timeline from 1967 (first description of ARDS) through
2011 and searched MEDLINE, EMBASE, CINAHL, and
the Cochrane Library, by using a combination of standar-
dized search terms and keywords covering the basic con-
cepts of acute lung injury, acute respiratory distress
syndrome, mechanical ventilation, ventilator-induced lung
injury, prevention, outcomes, and clinical trial. A trained
information professional experienced in systematic reviews
assisted in designing the search strategy and in conducting
the search. Two authors (BMF, NMM) also manually
screened the reference lists of the articles selected for
inclusion to identify additional studies. To identify poten-
tial unpublished data from clinical trials that have
completed enrollment, BMF and NMM also (a) manually
searched abstracts from the Society of Critical Care
Medicine, European Society of Intensive Care Medicine,
American Society of Anesthesiology, American Thoracic
Society, CHEST, and the Society of Academic Emergency
Medicine from 2008 to 2011; and (b) searched online for
details of clinical trials registration (http://ClinicalTrials.
gov). BMF also contacted principal investigators of pub-
lished and unpublished studies for clarification of potential
data for inclusion, as needed.
Inclusion criteria
Studies were eligible for review regardless of language or
publication type. We included randomized controlled
trials, prospective and retrospective cohort analyses, cross-
sectional studies, and before-and-after trials of adults
(older than 17 years) undergoing invasive positive-pressure
ventilation without ARDS at the time of initiation of
mechanical ventilation, and in which tidal volume was
independently studied (either retrospectively or prospec-
tively) as a predictor variable for outcome. We excluded
studies involving patients with established ARDS by
consensus criteria [2], studies of nonintubated patients
(e.g. noninvasive positive-pressure ventilation), studies of
one-lung ventilation, studies in which tidal volume was
not the only ventilator variable studied or manipulated
(e.g. tidal volume and positive end-expiratory pressure),
and studies in which the development of ARDS was not a
primary or secondary outcome measure. We also excluded
articles that were reviews, correspondence, editorials, and
nonhuman studies. We screened the reference list of all
review articles to identify additional studies for inclusion.
Corresponding authors were contacted, where appropriate,
for clarification of data or study type.
Study selection and data abstraction
Two reviewers (BMF and NMM) independently screened
the titles and abstracts of identified studies for potential
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eligibility. After this relevance screen, full text articles
were assessed for eligibility, and the two reviewers com-
pared their exclusion logs to determine whether there
was disagreement. All studies deemed potentially relevant
after the screen were obtained, and the full manuscripts
were reviewed for further exclusion. In cases of disagree-
ment, a third reviewer (AD) assessed the study, and a
consensus was reached between the three reviewers. Any
disagreements in this collection were resolved with a
consensus among the reviewers.
Assessment of study quality
We assessed the quality of clinical trials selected for inclu-
sion by using the Cochrane Collaboration’s tool for asses-
sing the risk of bias in clinical trials, evaluating four
domains: random sequence generation, concealment of
allocation, blinding, and selective outcome reporting [39].
High quality was defined as a grade of A in at least three
of the four methodology domains. For studies of observa-
tional design, each was assessed for its reporting of adher-
ence to the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) Statement [40].
Assessment of publication bias
Because detecting publication bias is difficult, we sought
to minimize bias through a medical librarian assisted
comprehensive search strategy and the use of study regis-
tries. We planned to use a graphic display (funnel plot) of
the size of the treatment effect against the precision of
the trial to evaluate for potential publication bias [41].
Data analysis
Our original intent, after conducting the systematic review,
was to conduct a meta-analysis of the data by using
Review Manager (RevMan, Version 5.1, Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration,
2011). However, because of qualitative heterogeneity
between the studies with respect to the patient popula-
tions studied and the baseline risk for ARDS development,




The comprehensive search yielded a total of 1,704
potentially relevant publications. Details regarding the
search, study selection, and reason for exclusion are
shown in Figure 1.
Inclusion
After the relevance search, a complete manuscript
review was performed on the remaining 52 articles.
Thirteen studies were included in the final analysis
[29-31,34,35,42-49]. The characteristics of the included
studies are shown in Table 1.
Study characteristics and outcomes reporting
The 13 studies were published over a 7-year period (2004
through 2011). One study was a randomized controlled
trial (RCT), and 12 were of observational trial design. On
the methodologic quality assessment, the RCT was rated
as high quality by Cochrane Collaboration’s tool for
assessing the risk of bias in clinical trials. In this trial,
Grade A was given for random-sequence generation
(sequence adequately generated), concealment of alloca-
tion (performed concealment allocation), and selective
outcome reporting (free of suggestion of selective out-
come reporting). For clinical trials in which blinding is
not feasible at the point of intervention (potential metho-
dologic issue for mechanical ventilation trials), high qual-
ity can still be assigned if the investigator collecting the
primary outcome is blinded to the treatment allocation.
This was unclear in the included RCT; therefore, a grade
C was given for blinding (unknown whether investigators
collecting the primary outcome were blinded to alloca-
tion). None of the 12 observational trials reported any
adherence to the STROBE guidelines [40]. Two of the
trials were multicenter studies (one retrospective registry
and one prospective observational trial), and 11 were per-
formed at a single center. Ten trials involved interven-
tions and patients in medical, surgical, neurologic,
trauma, or cardiac ICUs. Three trials were from the oper-
ating room. No studies examined mechanical ventilation
in the Emergency Department (ED). Two of the studies
were presented in abstract form only.
Significant heterogeneity was found with respect to the
patient population studied and the diagnoses leading to
respiratory failure (Table 1). Examples include cardiac
arrest, neurologic disorders such as subarachnoid hemor-
rhage and traumatic brain injury, postoperative patients,
sepsis, and elective surgical patients. Visual inspection of
the funnel plot (Figure 2) indicated potential publication
bias, because observed asymmetry suggested unpublished
research that favored not using low tidal volumes [41].
Although ARDS was defined according to the AECC cri-
teria in each of the studies, differences existed in given
criteria between studies [2]. For example, two studies
required the criteria to be fulfilled for 2 consecutive days
[29,45]; one study required criteria for 24 hours [47]; one
study required criteria for three consecutive arterial
blood gases [31]; and one study allowed the criterion of
left atrial hypertension to be determined at the discretion
of the attending physician, “with the modality of their
choice,” when a pulmonary artery catheter was not in
use, yet provided no further information on the diagnos-
tic modalities used [49]. Therefore, because of the very
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likely differences in baseline ARDS risk in the various
studies’ populations, as well as the uncertainty of diag-
nostic accuracy for ARDS, given the variable criteria used
to define it, a meta-analysis was not performed as had
been planned a priori.
Clinical outcomes
The results of the studies are shown in Table 2. In the
only RCT, a tidal volume of 6 ml/kg predicted body weight
(PBW) was associated with an absolute risk reduction of
10.9% for the development of ARDS (number needed to
treat of 9.2) when compared with 10 ml/kg PBW. The
observational studies included three operating room
studies (n = 58,419), one of which demonstrated an asso-
ciation between tidal volume and the development of
ARDS. However, in this largest trial included (n = 53,910)
in the review, the tidal volume difference between the two
groups was not clinically significant (0.1 ml/kg PBW).
Nine of the observational studies were from the ICU (n =























Figure 1 Search, inclusion, and exclusion flow diagram.
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Table 1 Study characteristics
Randomized controlled trial










150 VT 6 ml/kg
PBW vs. 10
ml/kg PBW
Medical/surgical ICU Cardiac arrest, neurologic
disease
YES Cytokine levels in
BAL and plasma













Excluded patients ventilated <48 hours






None mentioned Excluded patients ventilated <48 hours






Tidal volume obtained from author contact.




ICU LOS, VF days, ICU
mortality
Excluded patients with ARDS <24 hours from
admission
Yilmaz, 2007 375 Prospective,
before-after




ICU LOS, VF days
Excluded patients ventilated <48 hours
Plurad, 2007 2,346 Retrospective Surgical ICU Trauma NO Development of
late ARDS
Not mentioned Defined late ARDS as >48 hours after
admission
Iscimen, 2008 160 Prospective Medical ICU Septic shock NO Development of
ARDS
Hospital mortality,
hospital length of stay
Jia, 2008 789 Retrospective Medical/surgical/
cardiac ICUs
Unclear NO Development of
ARDS
Not mentioned Excluded patients ventilated <48 hours. 341
patients had data missing on VT/PBW




Not mentioned Abstract only
Hughes, 2010 89 Retrospective OR Abdominal, orthopedic,
vascular surgery within 24
hours of ICU admit
NO Development of
ARDS
Not mentioned Assessed outcomes for 7 days.
Excluded many risks for ARDS development




ASA I, II NO Development of
ARDS
Not mentioned Abstract only
Case-control study












Elective operations NO Postoperative
respiratory failure
due to ARDS
Length of stay, 60-day
survival, 1-year survival
Excluded patients with “prevalent” risk factors
for ARDS. 1st hour ventilator variables were
primary predictor variable
aAs assessed by Cochrane Collaboration’s tool for assessing risk of bias in clinical trials. Was assigned a grade of “A” (high quality) in the following methodology domains: random-sequence generation, concealment
of allocation, and selective outcome reporting; assigned a grade of “C” (unknown) in the following methodology domain: blinding. To explain, for trials in which blinding is not feasible at the point of intervention
(such as a tidal volume trial), a grade of “A” would be assigned if the investigator collecting the primary outcome were blinded to the treatment allocation. bFor the RCT, there was no reported assessment of
adherence to the ventilator/intervention protocol. cAs assessed by STROBE guidelines. ARDS, acute respiratory distress syndrome; ASA, American Society of Anesthesiologists; BAL, bronchoalveolar lavage; ICU,












volume or indexed to PBW) to be an independent predic-
tor of the development of ARDS. Five studies showed a
dose-response relation to tidal volume, with the propor-
tion of ARDS increasing with higher tidal volumes. No
study reported adverse clinical effects in association with a
lower tidal volume.
The time of ARDS onset was reported in seven stu-
dies, and occurred between days 2 and 4 (5 hours to 3.7
days). The incidence of ARDS was very low in the two
operating room studies involving primarily elective pro-
cedures: 0.2% and 1.9%. This is in contrast to a much
higher incidence in ICU patients, ranging from 6.2% to
44%.
In the studies comparing secondary outcomes between
ARDS and non-ARDS groups, the development of
ARDS increased mortality and morbidity. ARDS was
associated with an absolute increase in mortality of up
to 36%, increased ICU and hospital lengths of stay,
fewer ventilator-free days, and increased organ failure
(Table 3).
Discussion
In patients who do not have ARDS at the time of endo-
tracheal intubation, the preponderance of evidence
implies an association between lower tidal volume and
subsequent progression to ARDS. However, this sys-
tematic review could yield no definitive recommenda-
tions regarding the most appropriate tidal volume
strategy in patients without ARDS. Several important
caveats exist. An overall lack of data appears in the
existing body of literature, as well as a lack of methodo-
logic quality in the data that do exist. Of the 13 trials
included in this review, only one was a high quality
RCT, whereas the remainder were of observational trial
design. None of the observational trials referenced the
STROBE guidelines, which are endorsed by 110 journals
worldwide [50]. Publication guidelines like STROBE
were designed to standardize the reporting of medical
research to enhance transparency and minimize variabil-
ity [51]. An increasing body of evidence indicates that
the guidelines do improve the overall quality of research
reporting [52].
There was also substantial heterogeneity appeared in
the patient populations examined, each carrying perhaps
vastly different risk for ARDS progression. For example,
relatively healthy patients with a finite exposure to tidal
volume risk (operating room cases) are inherently differ-
ent in risk for progression compared with critically ill
ICU patients [53]. Furthermore, even among the studies
restricted to patients with longer exposure to tidal
volume (ICU patients), the diagnoses leading to
mechanical ventilation (Table 1) also carry very different
risk for ARDS (e.g. septic shock versus postoperative).
Funnel-plot inspection for the assessment of publication
bias revealed asymmetry suggestive of publication bias.
However, asymmetric funnel plots are not sufficient









Figure 2 Funnel plot for assessment of publication bias.
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proof of publication bias. Other potential explanations
for asymmetry include study-to-study heterogeneity with
the intervention fidelity or outcome assessment. Also,
improvement in the usual care in the “control” treatment
groups as routine management evolves over time may
reduce the observed effect size. It is also possible that an
asymmetric funnel plot is the result of chance alone [41].
Finally, differences were noted between studies in how a
Table 2 Study results
Randomized controlled trial










Determann, 2010 1.9 days 8% (n =12) 2.6% (n = 2) 13.5% (n = 10) 5.1 (1.2-22.6) 0.01 Trial stopped early for safety, due
to ARDS in control.
Observational studies
Cohort studies










Gajic, 2004 2.5 days 24% (n = 80) Unknown Unknown 1.29 (1.12-1.51) <0.001 Proportion of ARDS increased as
VT increased.
Gajic, 2005 Unknown 6.2% (n = 205) 670 ml ± 220c 620 ml ±110 c 1.26 (1.12-1.40) <0.001 Proportion of ARDS increased as
VT increased.




NS 0.06 ARDS development associated
with transfusion, SAH severity, and
PRBC transfusion.




5.54 (1.54-9.24) 0.008 Proportion of ARDS increased as
VT increased.
Yilmaz, 2007║ Unknown 28% (n = 60)
before
protocol; 10%
(n = 17) after
protocol
Unknown Unknown 1.31 (1.16-1.50) <0.001 Proportion of ARDS increased as
VT increased.




NS 0.383 ARDS associated with fluid
balance and PRBC transfusion




NS 0.362 Delayed antibiotics and
resuscitation associated with ARDS
Jia, 2008 3.3 days 19% (n = 152) 650.5 ml ±
119.7c
616.9 ml ± 112.8c 1.33 (1.09-1.62) 0.006 Proportion of ARDS increased as
VT increased. Transfusion, fluid
balance, airway pressures also
associated with ARDS. Mean VT in
patients that developed ARDS,
623.5 ml
Pasero, 2008 3.7 days 7% (n = 14) Unknown Unknown 2.04 (1.03-4.05) 0.042 Time of surgery and PEEP also
associated with ARDS




1.0 (0.3-3.2) 0.97 Intraoperative fluid >20 ml/kg/h
associated with ARDS
Blum, 2011 Unknown 0.2% (n = 102) 9.2 ml/kg
PBWc
9.1 ml/kg PBWc 0.77 (0.62-0.95) 0.02 PRBC transfusion strongest
predictor of ARDS
Case-control study
















1.03 (0.84-1.26) 0.801 Time of surgery, transfusion, and
fluid balance associated with
ARDS
ARDS, acute respiratory distress syndrome; NS, nonsignificant odds ratio (exact value and confidence interval not reported in original manuscript); OR, odds ratio;
PEEP, positive end-expiratory pressure; PRBC, packed red blood cell; SAH, subarachnoid hemorrhage; VT, tidal volume. aEach trial attempted to control for various
factors associated with development with ARDS, either with statistical analysis or trial design (for the RCT). bOR for risk of ARDS as a function of tidal volume.
cStatistically significant differences existed in VT between groups. dAdjusted OR for VT between ARDS cases and matched controls. eProtocol aimed at VT and
transfusion reduction. VT 10.6 ml/kg PBW (9.0-12.1) before protocol versus 7.7 ml/kg PBW (6.7-9.0).
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patient was classified as having developed ARDS, even
though each study required fulfillment of accepted con-
sensus criteria [2].
The results of this systematic review do reveal some
important trends in the data. First, each study that
reported ARDS onset showed that it occurs early in
mechanically ventilated at-risk patients. This may reflect
the difficulty in defining the precise onset of ARDS retro-
spectively, but also that many mechanically ventilated
patients may have early ARDS that has yet to manifest
clinically. This suggests that prevention trials should target
the most immediate time after initiation of mechanical
ventilation (e.g. in the ED, interhospital transport, and/or
the first 24 hours of ICU admission). Endotracheal intuba-
tion and initiation of mechanical ventilation is a common
occurrence in the ED, yet the effect that ED-based
mechanical ventilation may have on outcome has not been
studied [54]. However, preenrollment data from ARDS
clinical trials showed that early tidal volume did not influ-
ence mortality, further highlighting the equipoise on this
topic [55].
Second, the incidence of ARDS is very low when tidal
volume is studied in low risk patients in the operating
room (<2%). This is in contrast to the ICU, where the pro-
gression to ARDS appears to be a significant problem (as
high as 44%). However, in a cohort of higher-risk surgical
patients, higher tidal volumes have been associated with
other clinical outcomes, including greater nonpulmonary
organ failure and an increase in duration of mechanical
ventilation and ICU length of stay [56].
Third, although no definitive conclusions between tidal
volume and progression to ARDS can be made, based on
this systematic review, several findings in this body of evi-
dence suggest a link between higher tidal volumes and
progression to ARDS. Although almost all of the data are
observational trials, consistent findings across trial design
suggest a cause-effect relation [57]. In the only RCT exam-
ining this topic to date, tidal volume was predictive of pro-
gression to ARDS. Additionally, the majority of the
observational data demonstrate an increased ARDS inci-
dence with larger tidal volumes, which also suggests a cau-
sal link [57]. A dose-response relation (seen in five
studies), with the proportion of ARDS patients increasing
with higher tidal volumes, suggests cause-effect, as does
the fact that no findings appeared in the opposite direction
(no study showed lower tidal volumes to be harmful).
Fourth, the development of ARDS was associated with
many other factors across these trials. These include
patient-related (e.g. restrictive lung disease [29]), ventila-
tor-related (e.g. airway pressure [47]), and non ventilator-
related (e.g. fluid balance and transfusion [35,45,47,49])
factors. This further highlights that the development of
ARDS reflects an interaction between patient risk and
treatment variables, which was demonstrated before, and
suggests that the most effective ARDS-prevention strategy
may involve a multimodal approach (e.g. early resuscita-
tion, fluid management and type, lower tidal volume, high
transfusion threshold, and so on) [48,53]. In addition,
future ARDS-prevention trials will need to control for
each of these confounding variables while assessing patient
populations with similar baseline risk of progressing to
ARDS.
Finally, the progression to ARDS is associated with sig-
nificant increase in morbidity and mortality. In all trials
directly comparing ARDS versus no-ARDS groups, mor-
tality (up to fivefold increase), length of stay, and organ
failure were all increased with the development of the
syndrome. Although the best strategy to prevent the pro-
gression to ARDS has not been fully elucidated, it is clear
that its prevention should be a high priority in clinical
care and further research [58].
Important limitations exist in this systematic review.
The only RCT was stopped early, after an unplanned
interim analysis, because of safety concerns of ARDS
development in the 10-ml/kg PBW group [44]. Clinical
trials stopped early for benefit are increasing in preva-
lence, often lack information on why the trial was
stopped, and routinely show larger than expected treat-
ment effects [59]. The benefit of clinical trials stopped
Table 3 Clinical outcomes comparing ARDS and non-
ARDS groups
Outcome Author, year ARDS No
ARDS
p




Mascia, 2007 28% 22% NS
Hospital mortality Gajic, 2004 34% 24% 0.116
Gajic, 2005 62% 32%




ICU mortality Iscimen, 2008 38% 11%










VF days Gajic, 2004 17 22 0.007
Mascia, 2007 11 16 <0.05
Duration of MV
(days)
Kahn, 2006 14 8 <0.001
Renal failure Kahn, 2006 8% 2% <0.001
ARDS, acute respiratory distress syndrome; LOS, length of stay; MV,
mechanical ventilation; NS, nonsignificant; VF, ventilator free.
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early, including the trial in this review, should therefore
be viewed with caution. However, with 75% of the
planned enrollment achieved, and a very significant
between-group difference for the primary outcome (p =
0.01), confidence is increased that these results are
indeed valid.
Second, relatively few studies have examined ARDS
prevention and the role of tidal volume in the develop-
ment of ARDS. Existing studies are limited by their
observational trial design, and therefore any attempt to
analyze these studies as a group is limited by their indivi-
dual weaknesses.
Third, a meta-analysis of these data could not be con-
ducted as planned a priori, which differs from another
systematic review on this topic [60]. The patients were
not qualitatively similar and represent a spectrum of
patients from those with very little risk for ARDS (e.g.
elective surgery patients) to those with very high risk (e.g.
septic shock). When contemplating whether a systematic
review should become a meta-analysis, heterogeneity is
typically first addressed on a macroscopic level of the
individual study’s design, population, intervention(s), and
outcome measures. If sufficient differences exist between
individual studies such that lumping them together is
comparing “apples and oranges,” then a meta-analysis is
not appropriate. Systematic review authors should pro-
ceed to meta-analysis only if this first level of heterogene-
ity is assessed and deemed unlikely, an approach that has
been previously advocated [61]. We were therefore able
to conduct only a qualitative analysis of the data, as con-
ducting a meta-analysis would have served only to homo-
genize patients artificially. We recognize that these
limitations make drawing recommendations difficult
based on this systematic review, but with our inclusion of
an additional 10 studies (and >7,000 ICU patients) and
strict adherence to reporting guidelines, we believe this
current review to be the most complete and methodolo-
gically sound assessment of the literature to date.
The focus on early mechanical ventilation and ARDS
prevention is likely to increase. Recently the National
Heart, Lung and Blood Institute (NHLBI) recommended
the development of ARDS prevention trials, as well as
observational trials of patients without ARDS under-
going prolonged mechanical ventilation [58]. Given the
limited treatment options for ARDS, the period of
mechanical ventilation immediately after endotracheal
intubation is emerging as a critical time window of clini-
cal care and an opportunity for clinical trials to improve
outcome [58]. Our results are important in further high-
lighting knowledge gaps, which may serve in the future
design of ARDS prevention trials, and not only call
attention to the limitation of the literature, but also
highlight potential solutions for clinical trials going
forward. This includes RCTs targeting homogeneous
patient groups with higher event rates for ARDS pro-
gression and early timing of trial enrollment (e.g. imme-
diately after endotracheal intubation in the ED).
Factorial trial design aimed at limiting more than one
risk modifier for ARDS progression, such as tidal
volume and fluid balance, should be considered to maxi-
mize efficiency in this research arena [62]. Future
research should aim to minimize bias by incorporating
publishing guidelines such as the Consolidated Stan-
dards of Reporting Trials (CONSORT) for RCTs and
the STROBE for observational trials and should have
clinically relevant end points, such as progression to
ARDS or development of nonpulmonary organ failure as
a surrogate for ventilator-associated lung injury
[40,63,64]. Finally, to reduce efficiently the preventable
heterogeneity and variability in research and clinical
care in a sustainable fashion, interventions should be
simple, and reproducibility should be enhanced with the
aid of implementation science and electronic aids
[65-69]. Knowledge of factors influencing a lack of
adherence to beneficial therapy in ARDS may aid clini-
cians in translating research to routine care for preven-
tion of the syndrome as well [65,70]. These trials will
ultimately influence clinicians and change practice.
Therefore, analyzing critically what has and has not
been done is of vital importance.
Conclusions
Currently, no definitive recommendations can be made
on the most appropriate tidal volume strategy in
mechanically ventilated patients without ARDS. Data
suggest an increased incidence of ARDS with higher
tidal volumes, but previous studies are limited by their
heterogeneity and high variability in baseline ARDS risk
among the patients included. Given the increased mor-
tality and morbidity associated with progression to
ARDS, a focus on prevention should remain a high
priority for future research and clinical practice.
Key messages
• The majority of data suggest that higher tidal volumes
are causal in the development of ARDS.
• An overall lack of quality data prevents a definitive
recommendation for the most appropriate tidal volume
in patients with ARDS.
• ARDS occurs early in the course of mechanical ven-
tilation, suggesting that ARDS-prevention trials should
occur early in the course of mechanical ventilation, such
as in the emergency department.
• The development of ARDS is associated with signifi-
cant increases in mortality and morbidity, suggesting
that ARDS-prevention trials are needed.
Fuller et al. Critical Care 2013, 17:R11
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Additional material
Additional file 1: PROTOCOL: Search and identification of studies.
This is the search protocol and protocolized strategy, including the
inclusion and exclusion criteria that were used capture the studies for
this systematic review.
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